Ranieyes 2.30mg Injection
Marketer
Lupin Ltd
Salt Composition
Ranibizumab (2.30mg)
Overview Ranieyes 2.30mg Injection
Diabetic macular edema and macular degeneration are treated with a 2.30mg intravitreal injection of Ranieyes. This medication targets abnormal blood vessel growth and leakage within the eye, a leading cause of vision impairment. Administration must be performed by an ophthalmologist; self-injection is strictly prohibited. Potential side effects include eye pain, conjunctival bleeding, floaters, elevated intraocular pressure, and inflammation. Persistent side effects or any concerning symptoms warrant immediate medical attention. Driving is discouraged following injection due to the risk of temporary blurred vision.
Uses of Ranieyes 2.30mg Injection
Retinopathy in diabetes | Neovascular age-related macular degeneration | Macular swelling from retinal vein blockage
Major Benefits of Ranieyes 2.30mg Injection:
Administering this medication will be handled by your physician or registered nurse; self-medication is strictly prohibited.
Common Side effects of Ranieyes 2.30mg Injection:
- Conjunctival hemorrhage
- Eye pain
- Increased intraocular pressure
- Foreign body sensation in eyes
- Blurred vision
- Nausea
- Dry eye
- Eye itching
- Cataract
- Vitreous floaters
- Vitreous detachment
- Intraocular inflammation
- Eye irritation
- Increased lacrimation
- Eyelid inflammation
- Ocular hyperemia
- Retinal disorder
- Maculopathy
- Eye discomfort
- Posterior capsule opacification
- Injection site hemorrhage
- Nasopharyngitis (inflammation of the throat and nasal passages)
- Anemia (low number of red blood cells)
- Joint pain
- Renal failure
- Peripheral neuropathy (tingling and numbness of feet and hand)
- Gastro-esophageal reflux disease
- Hypercholesterolemia (high cholesterol)
- Bronchitis (inflammation of the airways)
How to use Ranieyes 2.30mg Injection:
Administering this medication will be handled by your healthcare provider. Self-medication is strongly discouraged.
How Ranieyes 2.30mg Injection works:
Ranieyes 2.30mg injection is an anti-angiogenesis agent. Its mechanism of action involves VEGF inhibition, thus preventing the formation and permeability of aberrant ocular blood vessels, thereby mitigating vision impairment.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Ranieyes 2.30mg Injection may pose safety risks; physician consultation is advised.
PregnancyCONSULT YOUR DOCTOR
Administering Ranieyes 2.30mg Injection during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the advantages against possible dangers prior to prescription. Seek medical advice.
Breast feedingSAFE IF PRESCRIBED
Administration of Ranieyes 2.30mg Injection while breastfeeding is likely safe. Available human data indicates minimal risk to the infant.
DrivingUNSAFE
Following administration of a 2.30mg Ranieyes injection, temporary blurred vision may occur. Refrain from driving until visual acuity returns to normal.
KidneySAFE IF PRESCRIBED
Ranieyes 2.30mg Injection appears to pose minimal risk for individuals with kidney impairment. Current evidence indicates that dosage modification may be unnecessary for this patient population. However, physician consultation is recommended.
LiverSAFE IF PRESCRIBED
The use of Ranieyes 2.30mg Injection in patients with hepatic impairment is likely safe. Existing evidence indicates dose modification may not be necessary; however, medical advice should be sought.
What if you forget to take Ranieyes 2.30mg Injection :
Should you forget a scheduled dose of Ranieyes 2.30mg Injection, seek immediate medical advice.
Facts to Know About Ranieyes 2.30mg Injection
| Label | Value |
|---|---|
| Chemical Category | Monoclonal antibody |
| Developing Habits | No. |
| Treatment Category | Ophthalmology |
| Behavior Class | AMD treatment with a VEGF inhibitor |
3,018 People bought this recently